Trademark: 98127327
Word
DREAMIR
Status
Pending
Status Code
681
Status Date
Thursday, May 2, 2024
Serial Number
98127327
Mark Type
3
Filing Date
Thursday, August 10, 2023
Published for Opposition
Tuesday, June 4, 2024

Trademark Owner History

Classifications
42 Research and development in the field of biotechnology, namely, RNA-based therapeutics; providing a secured-access, members only website featuring a proprietary technology software platform containing sequencing profiles and clinical outcome data that gives users the ability to obtain information for research purposes related to creating RNA-based therapeutics
The mark consists of an oval within which appears the word DREAMIR, with the "DREA" in uppercase font, the "mi" in lowercase font, and the "R" in uppercase font, along with images of a circle genomic sequencing , an antibody icon depiction and two human figures.
Color is not claimed as a feature of the mark.

Trademark Events
Aug 14, 2023
New Application Entered
Sep 11, 2023
New Application Office Supplied Data Entered
Sep 12, 2023
Notice Of Design Search Code E-Mailed
Apr 10, 2024
Assigned To Examiner
Apr 29, 2024
Examiners Amendment -Written
Apr 29, 2024
Examiners Amendment E-Mailed
Apr 29, 2024
Notification Of Examiners Amendment E-Mailed
Apr 29, 2024
Examiner's Amendment Entered
Apr 30, 2024
Approved For Pub - Principal Register

Trademark Alertz updated from USPTO on 2030-01-24